Stay updated with breaking news from Stephen Dipalma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
30.09.2022 - - Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases, led by industry veteran and current AavantiBio CEO, Bo Cumbo - - Strong synergies expected by combining key assets, including ...
Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer December 17, 2020 08:00 ET | Source: Spero Therapeutics, Inc. Spero Therapeutics, Inc. Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced the appointment ...
Published: Dec 17, 2020 CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced the appointment of Satyavrat “Sath” Shukla, CFA, as Chief Financial Officer, effective as of January 4, 2021. “Sath is an ideal fit for our management team given his experience leading financial strategy and executing within both clinical...